The Medical journal of Australia
-
To identify areas to improve patient management in lung cancer, which remains the greatest cause of death from cancer in Australia. ⋯ Opportunities to improve patient management included increasing the proportion with a pathologically confirmed diagnosis and greater use of postsurgical adjuvant chemotherapy. A high proportion of patients received no treatment, with underuse of chemotherapy and radiotherapy. Critically, the low rate of case discussions at MDMs needs to increase. However, effective strategies are required to identify cases early, as over two-thirds currently present with incurable disease.
-
Letter Case Reports
Re-treating bleeding hereditary haemorrhagic telangiectasia with bevacizumab.
-
Multicenter Study
Preventing breast and ovarian cancers in high-risk BRCA1 and BRCA2 mutation carriers.
To estimate the prevalence of the use of cancer risk-reducing measures among Australian BRCA1 and BRCA2 mutation carriers. ⋯ There is considerable scope to increase the uptake of cancer risk-reducing measures in Australian BRCA1 and BRCA2 mutation carriers. These findings should drive (i) future research into the factors contributing to low uptake in Australia and (ii) changes to policy and practice to help better translate genetic knowledge into reductions in cancer incidence.